No one suggests that a catchy song can fully eliminate serious pain. But several recent studies, including in the journals ...

Credit: Getty Images Researchers assessed the safety and efficacy of suzetrigine, a non-opioid pain signal inhibitor, on moderate to severe acute pain from in patients with surgical and nonsurgical ...

Acute back pain, affecting up to 80% of people, is a prevalent issue, especially among older individuals, causing discomfort and significantly impacting work and quality of life. A very common injury, ...

But the app is judged against subjective reports of pain. It might be useful for assessing the pain of people who can’t ...

SHANGHAI--(BUSINESS WIRE)--Xgene Pharmaceutical announced additional insights into the positive results of a multiple-center, placebo-controlled, dose-ranging Phase 2b study (registration number: ...

Q. Journavx works for me! I rarely need an opioid like Norco (hydrocodone and acetaminophen) or an NSAID like Celebrex when I’m on it. Now my pain specialist says it is limited to three months a year.

A new opioid-free pain medication was approved by the U.S. Food and Drug Administration (FDA) on Thursday, marking a non-addictive alternative for patients. Journavx (suzetrigine), made by Vertex, is ...